» Articles » PMID: 28112681

Acute Dietary Fat Intake Initiates Alterations in Energy Metabolism and Insulin Resistance

Abstract

Background: Dietary intake of saturated fat is a likely contributor to nonalcoholic fatty liver disease (NAFLD) and insulin resistance, but the mechanisms that initiate these abnormalities in humans remain unclear. We examined the effects of a single oral saturated fat load on insulin sensitivity, hepatic glucose metabolism, and lipid metabolism in humans. Similarly, initiating mechanisms were examined after an equivalent challenge in mice.

Methods: Fourteen lean, healthy individuals randomly received either palm oil (PO) or vehicle (VCL). Hepatic metabolism was analyzed using in vivo 13C/31P/1H and ex vivo 2H magnetic resonance spectroscopy before and during hyperinsulinemic-euglycemic clamps with isotope dilution. Mice underwent identical clamp procedures and hepatic transcriptome analyses.

Results: PO administration decreased whole-body, hepatic, and adipose tissue insulin sensitivity by 25%, 15%, and 34%, respectively. Hepatic triglyceride and ATP content rose by 35% and 16%, respectively. Hepatic gluconeogenesis increased by 70%, and net glycogenolysis declined by 20%. Mouse transcriptomics revealed that PO differentially regulates predicted upstream regulators and pathways, including LPS, members of the TLR and PPAR families, NF-κB, and TNF-related weak inducer of apoptosis (TWEAK).

Conclusion: Saturated fat ingestion rapidly increases hepatic lipid storage, energy metabolism, and insulin resistance. This is accompanied by regulation of hepatic gene expression and signaling that may contribute to development of NAFLD.REGISTRATION. ClinicalTrials.gov NCT01736202.

Funding: Germany: Ministry of Innovation, Science, and Research North Rhine-Westfalia, German Federal Ministry of Health, Federal Ministry of Education and Research, German Center for Diabetes Research, German Research Foundation, and German Diabetes Association. Portugal: Portuguese Foundation for Science and Technology, FEDER - European Regional Development Fund, Portuguese Foundation for Science and Technology, and Rede Nacional de Ressonância Magnética Nuclear.

Citing Articles

The development of a food-group, tree classification method and its use in exploring dietary associations with metabolic dysfunction-associated Steatotic liver disease (MASLD) and other health-related outcomes in a UK population.

Alawadi A, Vijay A, Grove J, Taylor M, Aithal G Metabol Open. 2025; 25:100351.

PMID: 39991490 PMC: 11847284. DOI: 10.1016/j.metop.2025.100351.


Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Hamamah S, Iatcu O, Covasa M Nutrients. 2025; 17(1.

PMID: 39796579 PMC: 11722922. DOI: 10.3390/nu17010143.


Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals.

Pesta D, Anadol-Schmitz E, Sarabhai T, Op den Kamp Y, Gancheva S, Trinks N Sci Adv. 2025; 11(1):eadr8849.

PMID: 39742483 PMC: 11691647. DOI: 10.1126/sciadv.adr8849.


Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC).

Misceo D, Mocciaro G, DAmore S, Vacca M Nutr Metab (Lond). 2024; 21(1):112.

PMID: 39716321 PMC: 11668039. DOI: 10.1186/s12986-024-00871-3.


Association Between Ultraprocessed Food Consumption and Metabolic Disorders in Children and Adolescents with Obesity.

Lee G, Lim J, Joung H, Yoon D Nutrients. 2024; 16(20).

PMID: 39458518 PMC: 11510381. DOI: 10.3390/nu16203524.


References
1.
Fan Y, Esmail M, Ansley S, Blacque O, Boroevich K, Ross A . Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet. 2004; 36(9):989-93. DOI: 10.1038/ng1414. View

2.
Mancini A, Imperlini E, Nigro E, Montagnese C, Daniele A, Orru S . Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health. Molecules. 2015; 20(9):17339-61. PMC: 6331788. DOI: 10.3390/molecules200917339. View

3.
Bachmann O, Dahl D, Brechtel K, Machann J, Haap M, Maier T . Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 2001; 50(11):2579-84. DOI: 10.2337/diabetes.50.11.2579. View

4.
Roden M, Stingl H, Chandramouli V, Schumann W, Hofer A, Landau B . Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes. 2000; 49(5):701-7. DOI: 10.2337/diabetes.49.5.701. View

5.
Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V . Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000; 49(12):2063-9. PMC: 2995498. DOI: 10.2337/diabetes.49.12.2063. View